Zobrazeno 1 - 4
of 4
pro vyhledávání: ''
Publikováno v:
Radiotherapy and Oncology, 101, 198-202
Radiotherapy and Oncology, 101, 1, pp. 198-202
Radiotherapy and Oncology, 101, 1, pp. 198-202
Contains fulltext : 97392.pdf (Publisher’s version ) (Closed access) BACKGROUND: Tribbles homolog 3 (TRIB3) is a pseudokinase involved in the regulation of several signaling pathways involved in cell survival and/or cell stress. Here, we determined
Autor:
Jacek Capala, Lars Franzén, Roger Henriksson, Annika Michanek, Sten-Åke Lindahl, A. Tommy Bergenheim, Leif G. Salford, Jan-Erik Westlin, Erik Blomquist
Publikováno v:
Radiotherapy and Oncology. 88:183-191
To evaluate the efficacy and safety of boron neutron capture therapy (BNCT) for glioblastoma multiforme (GBM) using a novel protocol for the boronophenylalanine-fructose (BPA-F) infusion.This phase II study included 30 patients, 26-69 years old, with
Autor:
Nobukazu Fuwa, Hiroyuki Tatibana, Akira Matsumoto, Makoto Kano, Takeshi Kodaira, Kazuhisa Furutani, Naoto Shikama, Minoru Kamata, Takafuni Toita
Publikováno v:
Radiotherapy and Oncology. 61:257-260
Alternating chemoradiotherapy was performed in 35 patients with locally advanced nasopharyngeal cancer. The median duration of follow-up was 20 months, and the 2-year progression free and overall survival rates were 83% (95% confidence interval: 66~1
Autor:
Eun Chang Choi, Sangwook Lee, Kwang Moon Kim, Sei Kyung Chang, Hee Chul Park, Hyeong Sik Lee, Sun Rock Moon, Gwi Eon Kim, Joo Hang Kim, Hong Ryull Pyo
Publikováno v:
Radiotherapy and Oncology. 61:261-269
Background and purpose : To clarify the clinical benefit derived from the combined modality therapy (CMT) comprised of chemotherapy and involved-field radiotherapy (XRT) for stage I and II angiocentric lymphomas of the head and neck. Material and met